Before initiating Zhewitra therapy, healthcare providers must conduct a comprehensive assessment of the patient's medical history, including any underlying health conditions and medications they are currently taking. Special attention should be paid to cardiovascular health; as certain cardiovascular conditions pose increased risks when combined with PDE5 inhibitors. Additionally, a thorough sexual health assessment is essential to determine the appropriateness of Zhewitra therapy.